尿路感染症に対するCefroxadine(CGP-9000)の臨床的検討 (Cefroxadine(CGP-9000,CXD)<特集>)
スポンサーリンク
概要
- 論文の詳細を見る
Sixty patients suffering from UTI were treated with Cefroxadine (CGP-9000, CXD) a new orally active cephalosporin. The results are as follows.<BR>1) Of 38 acute cystitis cases, excellent response was seen in 35 and good in 1.<BR>2) All of 11 prostatocystitis cases, responded excellently to CXD. (including 2 cases having benign prostatic hypoplasia)<BR>3) Of 4 chronic complicated cystitis cases one excellent and one good responses were observed.<BR>4) In upper urinary tract infection (pyelonephritis), good response was seen in all 4 acute simple infections and 2 of 3 complicated infections.<BR>5) As a total, 55 of 60cases responded favorably to CXD.<BR>6) 66 strains were isolated from these 60 cases. Of them 6 strains were persistently cultured during CXD administration. 2 <I>Klebsiella</I> strains, 1 <I>Proteus mirabilis</I>, 1 <I>Proteus morganii</I>, 1 <I>Serratia marcescence</I> were the strains persisted.<BR>7) No untoward reaction or abnormal laboratory data was observed in any case.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.